Page 133 - Prostate News Today

Proof-of-concept immuno-oncology collaboration with AstraZeneca to build understanding of prostate cancer Alchemab's advanced analytics to be used to analyse patient immune responses, identify

Arresting tumor growth for a variety of cancers through T cell engineering Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that its possible to arrest tumor growth for a variety of cancers and squash the spread of cancer to other tissues. This research will be published in tomorrows print edition of Cancer Research. The paper builds on decades of research by study co-senior author Paul B. Fisher, M.Ph., Ph.D., a member of Masseys Cancer Bio...

St Andrew’s Toowoomba Hospital celebrated its 1,000th robot surgery since 2014 The surgical team at St Andrew’s Toowoomba Hospital in Queensland has celebrated a technological milestone, with the 1,000th patient treated using robotic-assisted surgery. St Andrew’s started using the advanced surgical method in 2014, becoming the first regional hospital in Australia to implement the system. In April 2021, gynaecologist Dr Anthony Cerqui performed the landmark 1,000th robotic-assisted case, u...

Thousands of men to trial new home test kit for prostate cancer Apr 30 2021 Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH). Image Credit: University of East Anglia The research team are trialing a new home-testing ‘Prostate Screening Box’ to collect men’s urine samples at-home. The urine samples will be used to analyze the health of the...

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein that is crucial for the function of testosterone - may destroy cancer cells. The study, published in the April 28, 2021 issue of Cancer Letters is import...

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline. Heightened leve...

CU Cancer Center researchers receive PRCRP grant to investigate metastasis Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defenses Peer Reviewed Cancer Research Program (PRCRP). Founded in 2009, the PRCRP funds cancer research to support service members, their families, and the American public. Since members of the military are exposed to hazardous environments due to the nature of their service and are at risk for the d...

MUSC Hollings Cancer Center is enrolling patients in a national clinical trial to help to determine the best, most cost-effective approach for treating...

Massachusetts General Hospital For many patients with localized lung cancer (non-small-cell lung carcinoma and small cell lung carcinoma), high-dose radiation with concurrent chemotherapy is a potential cure. Yet this treatment can cause severe, acute inflammation of the esophagus (esophagitis) in about one in five patients, requiring hospitalization and placement of a feeding tube. A team of radiation oncologists at Mass General Cancer Center demonstrate in an early clinical trial that the rad...

New efforts to improve the efficacy of nucleotide-based drugs against prostate cancer, bone metastasis Published in the Advanced Functional Materials, University of Minnesota researcher Hongbo Pang led a cross-institutional study on improving the efficacy of nucleotide-based drugs against prostate cancer and bone metastasis. In this study, Pang and his research team looked at whether liposomes, when integrated with the iRGD peptide, will help concentrate antisense oligonucleotides (ASOs) into ...